Merck's Hypertension Drug On FDA Fast Track For Label Expansion

benzinga.com/news/fda/25/07/46230333/mercks-hypertension-drug-on-fda-fast-track-for-label-expansion

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review for Merck & Co. Inc.’s (NYSE:MRK) new supplemental Biologics License Application (sBLA) seeking approval to update the U.S. product label based on the Phase 3 ZENITH trial for Winrevair…

This story appeared on benzinga.com, 2025-07-02 18:43:46.
The Entire Business World on a Single Page. Free to Use →